Position
Marex Group plc in Cigna Group
Back to the book · All holders of CI
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.02M$275.23 → $266.75
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2022 | 55K | $18.2M | — | — | — | 2.6% |
| Q1 2023 | 110K | $28.1M | $255.53 | −$4.14M | $14.1M | 3.7% |
| Q2 2023 | 260K | $73M | $280.60 | $2.76M | $42.1M | 13.2% |
| Q4 2023 | 72.5K | $21.7M | $299.45 | $1.37M | −$52.6M | 0.9% |
| Q1 2024 | 72.9K | $26.5M | $363.19 | $4.62M | $140.6K | 0.9% |
| Q2 2024 | 759 | $250.9K | $330.57 | −$24.8K | −$26.2M | 0.0% |
| Q3 2024 | 100.2K | $34.7M | $346.44 | $12K | $34.4M | 0.8% |
| Q4 2025 | 168.5K | $46.4M | $275.23 | −$7.13M | $18.8M | 0.3% |
| Q1 2026 | 120.4K | $32.1M | $266.75 | −$1.02M | −$13.2M | 0.2% |